Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide versus sodium valproate adjunctive therapy for cognition in partial epilepsy
NL-OMON32279Phase 4Withdrawn
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in epilepsy comparing Adjunctive Zonegran arm with Adjunctive Epilim arm (2 arms). Planned start Apr 2008; status: withdrawn.
02
Drugs
zonisamidevalproic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON32279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32279.